
About Genitech Vnsan Pharmaceuticals Private Limited
Data last updated:
Genitech Vnsan Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52609DL2018PTC343129. Its GSTIN is 06AAHCG5985E1ZD (Haryana). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.01 Lakh. It is led by directors including Deepak Kumar and Atul Kumar.
Its last annual general meeting (AGM) was held on 28 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S – 550/551 G/F School Block II Shakarpur, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2026, the company reported a revenue of ₹4.8 Cr, a decline of 78% compared to the previous year. For the same year it recorded a net profit of ₹3.11 Cr (net margin 64.8%) and EBITDA of ₹3.84 Cr (EBITDA margin 79.9%). Revenue has declined at a compounded annual rate (CAGR) of 49% over three years and 17% over five years.
The company has about 171 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Apna Chemist. The company has 1 deal on record (1 funding round), with disclosed funding of ₹1.6 Cr; the latest was in December 2021. The company has 5 MSME Form 1 returns on record between 2023 and 2024, listing 48 overdue payments to 22 micro and small suppliers.
For more details, the company can be reached via its website apnachemist.com.
Company details
Contact details
Genitech Vnsan Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is apnachemist.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressS – 550/551 G/F School Block II Shakarpur, New Delhi, Delhi, India – 110092
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Genitech Vnsan Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Genitech Vnsan Pharmaceuticals operates one associated brand: Apna Chemist. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Online pharmacy offers a variety of healthcare products | apnachemist.com |
Business activity
The main business activity of Genitech Vnsan Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Genitech Vnsan Pharmaceuticals Private Limited, buy the company report.
Financials of Genitech Vnsan Pharmaceuticals Private Limited
FY 2025 filings availableGenitech Vnsan Pharmaceuticals Private Limited reported revenue of ₹4.8 Cr (down 78% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 17% over five years, including a 78% fall in the latest year. EBITDA rose 145% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.84 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.11 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 79.9% | ||||
| Net Profit Margin | 64.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Genitech Vnsan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Genitech Vnsan Pharmaceuticals Private Limited
Genitech Vnsan Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Atul Kumar Also directs: Solitaire Softech LLP, Fantasy Buildwell Private Limited, Sepset Properties Private Limited and 5 more | Additional Director | 01 Nov 2025 | 0 Years 11 Months | Current |
| Deepak Kumar | Director | 01 Jun 2023 | 3 Years 4 Months | Current |
| Vijay Kumar Verma Also directs: Imperial Housing Ventures Private Limited, Reliant Township Private Limited, Paras Seasons Haven Private Limited and 3 more | Additional Director | 11 Sep 2025 | 1 Years 1 Months | Current |
Auditor
Genitech Vnsan Pharmaceuticals Private Limited is audited by ABNG & Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ABNG & Company | FY 2023 | 027223N |
Shareholding
The shareholding of Genitech Vnsan Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Genitech Vnsan Pharmaceuticals Private Limited, buy the company report.
Deals & funding
Genitech Vnsan Pharmaceuticals Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹1.6 Cr; the latest was in December 2021.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2021 | Funding round | ₹1.6 Cr | Investors: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Genitech Vnsan Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Genitech Vnsan Pharmaceuticals Private Limited has 5 MSME Form 1 returns on record between 2023 and 2024, listing 48 overdue payments to 22 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 22)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Amar Medical Store | |||
| an individual supplier | |||
| Novacare Healthcare Solutions Private Limited | |||
| Advay Consumer Care Private Limited |
To see the full MSME payment records of Genitech Vnsan Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Genitech Vnsan Pharmaceuticals Private Limited has a workforce of 171 employees on its EPFO records as of Apr 10, 2024, across 1 active EPFO establishment.
GST
Genitech Vnsan Pharmaceuticals has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAHCG5985E1ZD | Haryana | Active | 09 Jan 2019 |
| 09AAHCG5985E1Z7 | Uttar Pradesh | Active | 04 Sep 2020 |
To see the full GST registrations and return filing status of Genitech Vnsan Pharmaceuticals Private Limited, buy the company report.
Recent activity
Genitech Vnsan Pharmaceuticals Private Limited has 7 board changes on record since 2022: 3 appointments and 4 cessations. The latest: Atul Kumar was appointed as Additional Director on 01 Nov 2025.
Frequently asked questions
Genitech Vnsan Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 December 2018 (8+ years old) and is registered under CIN U52609DL2018PTC343129.
Genitech Vnsan Pharmaceuticals has 3 current directors:
- Atul Kumar - Additional Director
- Deepak Kumar - Director
- Vijay Kumar Verma - Additional Director
The latest financial statements of Genitech Vnsan Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 August 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Genitech Vnsan Pharmaceuticals is 06AAHCG5985E1ZD, registered in Haryana. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 09AAHCG5985E1Z7 (Uttar Pradesh).
The CIN (Corporate Identification Number) of Genitech Vnsan Pharmaceuticals is U52609DL2018PTC343129. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genitech Vnsan Pharmaceuticals was incorporated on 17 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Genitech Vnsan Pharmaceuticals has 1 deal on record (1 funding round), with disclosed funding of ₹1.6 Cr; the latest was in December 2021.
Atul Kumar was appointed as Additional Director on 01 Nov 2025. Vijay Kumar Verma was appointed as Additional Director on 11 Sep 2025. Deepak Kumar ceased to be Additional Director on 21 Sep 2023. Genitech Vnsan Pharmaceuticals has 7 board changes on record in total.
Genitech Vnsan Pharmaceuticals has 5 MSME Form 1 returns on record between 2023 and 2024, listing 48 overdue payments to 22 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Genitech Vnsan Pharmaceuticals can be reached through the website apnachemist.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Genitech Vnsan Pharmaceuticals is at S – 550551 GF School Block II Shakarpur, New Delhi, Delhi, India – 110092.

